Search

everythinglearnresearchcommunity

for

Search:↓

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Feminizing hormone therapy increases kidney filtration rate.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.